Overcoming aminoglycoside enzymatic resistance: Design of novel antibiotics and inhibitors

Molecules

Volumn 23, Issue 2, 2018, Pages

  Zárate, Sandra G ^a   De La Cruz Claure, M Luisa ^a   Benito Arenas, Raúl ^b   Revuelta, Julia ^b   Santana, Andrés G ^b   Bastida, Agatha ^b  

^a Sucre   (Bolivia)

^b INSTITUTO DE QUÍMICA ORGÁNICA GENERAL   (Spain)

Author keywords

Antibiotic resistance; Bi substrate inhibitors; Combination therapy; Decoy acceptors

Indexed keywords

AMINOGLYCOSIDE; ANTIINFECTIVE AGENT;

ANIMAL; ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; BACTERIUM; CHEMISTRY; DRUG EFFECT; GENETICS; HUMAN; METABOLISM;

AMINOGLYCOSIDES; ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; DRUG RESISTANCE, BACTERIAL; HUMANS;

EID: 85041598769     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules23020284     Document Type: Review

References (113)

1. Davies, J.; Davies, D. Origins and evolution of antibiotic resistance. Microbiol. Mol. Biol. Rev. 2010, 74, 417-433.
2. Livermore, D. M. Fourteen years in resistance. Int. J. Antimicrob. Agents 2012, 39, 283-294.
3. Arias, C. A.; Murray, B. E. Antibiotic-resistant bugs in the 21st century-A clinical super-challenge. N. Engl. J. Med. 2009, 360, 439-443.
4. Greenwood, D.; Finch, R.; Davey, P.; Wilcox, M. Antimicrobial Chemotherapy, 4th ed.; Oxford University Press: Oxford, UK, 2000; pp. 32-48. ISBN 9780192631954.
5. Chen, G.-H.; Pan, P.; Yao, Y.; Cheng, Y.; Meng, X.-B.; Li, Z.-J. Regioselective modification of amino groups in aminoglycosides based on cyclic carbamate formation. Tetrahedron 2008, 64, 9078-9087.
6. Chen, G.-H.; Pan, P.; Yao, Y.; Chen, Y.; Meng, X.-B.; Li, Z.-J. Selective deprotection of the Cbz amine protecting group for the facile synthesis of kanamycin A dimers linked at N-3" position Original. Tetrahedron 2009, 65, 5922-5927.
7. Umezawa, H.; Okanishi, M.; Kondo, S.; Hamana, K.; Utahara, R.; Maeda, K.; Mitsuhashi, S. Phosphorylative inactivation of aminoglycosidic antibiotics by Escherichia coli carrying R factor. Science 1967, 157, 1559-1561.
8. Doi, O.; Miyamoto, M.; Tanaka, N.; Umezawa, H. Inactivation and phosphorylation of kanamycin by drug-resistant Staphylococcus aureus. Appl. Microbiol. 1968, 16, 1282-1284.
9. Miller, G. H.; Sabatelli, F. J.; Naples, L.; Hare, R. S.; Shaw, K. J. The changing nature of aminoglycoside resistance mechanisms and the role of isepamicin-A new broad-spectrum aminoglycoside. The Aminoglycoside Resistance Study Groups. J. Chemother. 1995, 7, 31-44.
10. Mitscher, L. A. Antibiotics and Antimicrobial Agents; Lippincott Williams & Wilkins: Baltimore, PA, USA, 2002; pp. 788-791.
11. Weinstein, M. J.; Luedemann, G. M.; Oden, E. M.; Wagman, G. H. Gentamicin, a new broad-spectrum antibiotic complex. Antimicrob. Agents Chemother. 1963, 161, 1-7.
12. Martin, C. M.; Ikari, N. S.; Zimmerman, J.; Waitz, J. A. A virulent nosocomial Klebsiella with a transferable R factor for gentamicin: Emergence and suppression. J. Infect. Dis. 1971, 124, 24-29.
13. Benveniste, R.; Davies, J. R-factor mediated gentamicin resistance: A new enzyme which modifies aminoglycoside antibiotics. FEBS Lett. 1971, 14, 293-296.
14. Woo, P.; Dion, H.; Bartz, Q. Butirosins A and B, aminoglycoside antibiotics. III. structures. Tetrahedron Lett. 1971, 12, 2625-2628.
15. Hayashi, S. F.; Norcia, L. J.; Seibel, S. B.; Silvia, A. M. Structure activity relationships of hygromycin A and its analogs: Protein synthesis inhibition activity in a cell free system. J. Antibiot. 1997, 50, 514-521.
16. Shaw, K. J.; Rather, P. N.; Hare, R. S.; Miller, G. H. Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiol. Rev. 1993, 57, 138-163.
17. Hotta, K.; Zhu, C. B.; Ogata, T.; Sunada, A.; Ishikawa, J.; Mizuno, S.; Kondo, S. Enzymatic 2'-N-acetylation of arbekacin and antibiotic activity of its product. J. Antibiot. 1996, 49, 458-464.
18. Labby, K. J.; Garneau-Tsodikova, S. Strategies to overcome the action of aminoglycoside-modifying enzymes for treating resistant bacterial infections. Future Med. Chem. 2013, 5.
19. Gillings, M. R.; Paulsen, I. T.; Tetu, S. G. Genomics and the evolution of antibiotic resistance. Ann. N. Y. Acad. Sci. 2017, 1388, 92-107.
20. Wolf, E.; Vassilev, A.; Makino, Y.; Sali, A.; Nakatani, Y.; Burley, S. K. Crystal structure of a GCN5-related N-acetyltransferase: Serratia marcescens aminoglycoside 3-N-acetyltransferase. Cell 1998, 94, 439-449.
21. Vetting, M. W.; Hegde, S.; Javid-Majd, F.; Blanchard, J. S.; Roderick, S. L. Aminoglycoside 20-N-acetyltrasferase from Mycobacterium tuberculosis in complex with coenzyme A and aminoglycoside substrates. Nat. Struct. Biol. 2002, 9, 653-658.
22. Lovering, A. M.; White, L. O.; Reeves, D. S. AAC-(1): A new aminoglycoside-acetylating enzyme modifying the Cl aminogroup of apramycin. J. Antimicrob. Chemother. 1987, 20, 803-813.
23. Sunada, A.; Nakajima, M.; Ikeda, Y.; Kondo, S.; Hotta, K. Enzymatic 1-N-acetylation of paromomycin by an actinomycete strain 8 with multiple aminoglycoside resistance and paromomycin sensitivity. J. Antibiot. 1999, 52, 809-814.
24. Brenner, S. Phosphotransferase sequence homology. Nature 1987, 329, 6134.
25. Burk, D. L.; Hon, W. C.; Leung, A. K.; Berghuis, A. M. Structural analysis of nucleotide binding to an aminoglycoside phosphotransferase. Biochemistry 2001, 40, 8756-8764.
26. Fong, D. H.; Berghuis, A. M. Substrate promiscuity of an aminoglycoside antibiotic resistance enzyme via target mimicry. EMBO J. 2002, 21, 2323-2331.
27. Norris, A. L.; Serpersu, E. H. Ligand promiscuity through the eyes of the aminoglycoside N3 acetyltransferase IIa. Protein Sci. 2013, 22, 916-928.
28. Thompson, P. R.; Hughes, D. W.; Wright, G. D. Regiospecificity of aminoglycoside phosphotransferase from Enterococci and Staphylococci (APH (3')-IIIa). Biochemistry 1996, 35, 8686-8695.
29. McKay, G. A.; Wright, G. D. Kinetic mechanism of aminoglycoside phosphotransferase type IIIa. Evidence for a Theorell-Chance mechanism. J. Biol. Chem. 1995, 270, 24686-24692.
30. Cox, G.; Stogios, P. J.; Savchenko, A.; Wright, G. D. Structural and Molecular Basis for Resistance to Aminoglycoside Antibiotics by the Adenylyltransferase ANT (2")-Ia. Mbio 2015, 6.
31. Bassenden, A. V.; Rodionov, D.; Shi, K.; Berghuis, A. M. Structural Analysis of the Tobramycin and Gentamicin Clinical Resistome Reveals Limitations for Next-generation Aminoglycoside Design. ACS Chem. Biol. 2016, 11, 1339-1346.
32. Chen, Y.; Nasvall, J.; Wu, S.; Andersson, D. I.; Selmer, M. Crystal structure of AadA an aminoglycoside adenyltransferase. Acta Crystallogr. D Biol. Crystallogr. 2015, 71, 2267.
33. Pedersen, L. C.; Benning, M. M.; Holden, H. M. Structural investigation of the antibiotic and ATP-binding sites in kanamycin nucleotidyltransferase. Biochemistry 1995, 34, 13305-13311.
34. Stogios, P. J.; Wawrzak, Z.; Minasov, G. A.; Evdokimova, E.; Egorova, O.; Yim, V.; Kudritska, M.; Courvalin, P.; Savchenko, A.; Anderson, W. F. Crystal structure of aminoglycoside 4'-O-adenylyltransferase ANT (4')-IIb, apo. Cent. Struct. Genom. Infect. Dis. (CSGID) 2012.
35. Tyagi, R.; Eswaramoorthy, S.; Burley, S. K.; Swaminathan, S. New York SGX Research Center for Structural Genomics. Crystal structure of an aminoglycoside 6-adenyltransferase from Bacillus subtilis. Unpublished work. 2007.
36. Murphy, E. Nucleotide sequence of a spectinomycin adenyltransferase AAD (9) determinant from Staphylococcus aureus and its relationship to AAD (3') (9). Mol. Gen. Genet. 1985, 200, 33-39.
37. Matesanz, R.; Díaz, J. F.; Corzana, F.; Santana, A. G.; Bastida, A.; Asensio, J. L. Multiple keys for a single lock: The unusual structural plasticity of the nucleotidyltransferase (4')/kanamycin complex. Chemistry 2012, 18, 2875-2889.
38. Revuelta, J.; Corzana, F.; Bastida, A.; Asensio, J. L. The unusual nucleotide recognition properties of the resistance enzyme ANT (4'): Inorganic tri/polyphosphate as a substrate for aminoglycoside inactivation. Chem. A Eur. J. 2010, 16, 8635-8640.
39. Chen-Goodspeed, M.; Vanhooke, J. L.; Holden, H. M.; Raushel, F. M. Kinetic mechanism of kanamycin nucleotidyltransferase from Staphylococcus aureus. Bioorg. Chem. 1999, 27, 395-408.
40. Magnet, S.; Blanchard, J. S. Molecular Insights into Aminoglycoside Action and Resistance. Chem. Rev. 2005, 105, 477-497.
41. Van Pelt, J. E.; Northrop, D. B. Purification and properties of gentamicin nucleotidyltransferase from Escherichia coli: Nucleotide specificity, pH optimum, and the separation of two electrophoretic variants. Arch. Biochem. Biophys. 1984, 230, 250-263.
42. Ramirez, M. S.; Tolmasky, M. E. Aminoglycoside Modifying Enzymes. Drug Resist. Update 2010, 13, 151-171.
43. Gates, C. A.; Northrop, D. B. Alternative substrate and inhibition kinetics of aminoglycoside nucleotidyltransferase 2"-I in support of a Theorell-Chance kinetic mechanism. Biochemistry 1988, 27, 3826-3833.
44. Bacot-D, V. R.; Bassenden, A. V.; Sprules, T.; Berghuis, A. M. Effect of solvent and protein dynamics in ligand recognition and inhibition of aminoglycoside adenyltransferase 200-Ia. Protein Sci. 2017, 26, 1852-1863.
45. Corzana, F.; Cuesta, I.; Bastida, A.; Hidalgo, A.; Latorre, M.; González, C.; García-Junceda, E.; Jiménez-Barbero, J.; Asensio, J. L. Molecular recognition of aminoglycoside antibiotics by bacterial defense proteins: NMRanalysis of Streptomycin inactivation by Bacillus subtilis Aminoglycoside-6-adenyl Transferas. Chem. Eur. J. 2005, 11, 5102-5113.
46. Latorre, M.; Revuelta, J.; García-Junceda, E.; Bastida, A. 6-O-Nucleotidyltransferase: An aminoglycosidemodifying enzyme specific for streptomycin/streptidine. MedChemComm 2016, 7, 177-183.
47. Ferretti, J. J.; Gilmore, K. S.; Courvalin, P. Nucleotide-sequence analysis of the gene specifying the bifunctional 6'-aminoglycoside acetyltransferase 2"-aminoglycoside phosphotransferase enzyme in Streptococcus faecalis and identification and cloning of gene regions specifying the two activities. J. Bacteriol. 1986, 167, 631-638.
48. Yildiz, Ö.; Çoban, A. Y.; Şener, A. G.; Coşkuner, S. A.; Bayramoǧlu, G.; Güdücüoǧlu, H.; Özyurt, M.; Tatman-Otkun, M.; Karabiber, N.; Özkütük, N.; et al. Antimicrobial susceptibility and resistance mechanisms of methicillin resistant Staphylococcus aureus isolated from 12 Hospitals in Turkey. Ann. Clin. Microbiol. Antimicrob. 2014, 16, 44-49.
49. Centron, D.; Roy, P. H. Presence of a group II intron in a multiresistant Serratia marcescens strain that harbors three integrons and a novel gene fusion. Antimicrob. Agents Chemother. 2002, 46, 1402-1409.
50. Dubois, W.; Poirel, L.; Marie, C.; Arpin, C.; Nordmann, P.; Quentin, C. Molecular characterization of a novel class 1 integron containing blaGES-1 and a fused product of aac (3)-Ib/aac (6')-Ib' gene cassettes in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 2002, 46, 638-645.
51. Kim, C.; Hesek, D.; Zajícek, J.; Vakulenko, S. B.; Mobashery, S. Characterization of the bifunctional aminoglycoside-modifying enzyme ANT (3")-Ii/AAC (6')-IId from Serratia marcescens. Biochemistry 2006, 45, 8368-8377.
52. Kim, C.; Villegas-Estrada, A.; Hesek, D.; Mobashery, S. Mechanistic characterization of the bifunctional aminoglycoside-modifying enzyme AAC (3)-Ib/AAC (6')-Ib' from Pseudomonas aeruginosa. Biochemistry 2007, 46, 5270-5282.
53. Shaul, P.; Green, K. D.; Rutenberg, R.; Kramer, M.; Berkov-Zrihen, Y.; Breiner-Goldstein, E.; Garneau-Tsodikova, S.; Fridman, M. Assessment of 6'- and 6""-N-acylation of aminoglycosides as a strategy to overcome bacterial resistance. Org. Biomol. Chem. 2011, 9, 4057-4063.
54. Bastida, A.; Hidalgo, A.; Chiara, J. L.; Torrado, M.; Corzana, F.; Pérez-Cañadillas, J. M.; Groves, P.; García-Junceda, E.; González, C.; Jiménez-Barbero, J.; et al. Exploring the use of conformationally locked aminoglycosides as a new strategy to o.vercome bacterial resistance. J. Am. Chem. Soc. 2006, 128, 100-116.
55. Fair, R. J.; McCoy, L. S.; Hensler, M. E.; Aguilar, B.; Nizet, V.; Tor, Y. Singly modified amikacin and tobramycin derivatives show increased rRNA A-site binding and higher potency against resistant bacteria. ChemMedChem 2014, 9, 2164-2171.
56. Fair, R. J.; Hensler, M. E.; Thienphrapa, W.; Dam, Q. N.; Nizet, V.; Tor, Y. Selectively guanidinylated aminoglycosides as antibiotics. ChemMedChem 2012, 7, 1237-1244.
57. Yang, L.; Ye, X-S. Development of Aminoglycoside Antibiotics Effective Against Resistant Bacterial Strains. Curr. Top. Med. Chem. 2010, 10, 1898-1926.
58. Yan, R.-B.; Yuan, M.; Wu, Y.; You, X.; Ye, X.-S. Rational design and synthesis of potent aminoglycoside antibiotics against resistant bacterial strains. Bioorg. Med. Chem. 2011, 19, 30-40.
59. Umezawa, H.; Umezawa, S.; Tsuchiya, T.; Okazaki, I. 3', 4'-Dideoxykanamycin B active against kanamycinresistant Escherichia coli and Pseudomonas aeruginosa. J. Antibiot. 1971, 24, 485-487.
60. Schmidt, F. R.; Nucken, E. J.; Henschke, R. B. Nucleotide sequence analysis of 2"-aminoglycoside nucleotidyl-transferase ANT (2") from Tn4000: Its relationship with AAD (3') and impact on Tn21 evolution. Mol. Microbiol. 1988, 2, 709-717.
61. Daigle, D. M.; Hughes, D. W.; Wright, G. D. Prodigious substrate specificity of AAC (6')-APH (2"), an aminoglycoside antibiotic resistance determinant in enterococci and staphylococci. Chem. Biol. 1999, 6, 99-110.
62. Woo, P. W. K.; Haskell, T. H. Deoxy derivatives of butirosin A and 5"-amino-5"-deoxybutirosin A, aminoglycoside antibiotics resistant to bacterial 3'-phosphorylative enzymatic inactivation. Synthesis and NMR studies. J. Antibiot. 1982, 35, 692-702.
63. Maeda, K.; Fujii, F.; Kondo, S.; Umezawa, H. Chemical derivation of antibiotics active against resistant bacteria. Jpn. J. Med. Sci. Biol. 1967, 21, 224-227.
64. Kagawuchi, H.; Naito, T.; Nakagawa, S.; Fujisawa, K. I. B-K8, a new semisynthetic aminoglycoside antibiotic. J. Antibiot. 1972, 25, 695-708.
65. Kim, Y. A.; Park, Y. S.; Youk, T.; Lee, H.; Lee, K. Correlation of Aminoglycoside Consumption and Amikacinor Gentamicin-Resistant Pseudomonas aeruginosa in Long-Term Nationwide Analysis: Is Antibiotic Cycling an Effective Policy for Reducing Antimicrobial Resistance? Ann. Lab. Med. 2018, 38, 176-178.
66. Kondo, S.; Iinuma, K.; Yamamoto, H.; Maeda, K.; Umezawa, H. Letter: Synthesis of 1-N-{(S)-4-amino-2-hydroxybutyryl}-kanamycin B and -3', 4'-dideoxykanamycin B active against kanamycin resistant bacteria. J. Antibiot. 1973, 26, 412-415.
67. Ubutaka, K.; Yamashita, N.; Gotoh, A.; Konno, M. Purification and characterization of aminoglycosidemodifying enzymes from Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob. Agents Chemother. 1984, 25, 754-759.
68. Kondo, S.; Hotta, K. Semisynthetic aminoglycoside antibiotics: Development and enzymatic modifications. J. Infect. Chemother. 1999, 5, 1-9.
69. Bennett, J. E.; Dolin, R.; Blaser, M. Principles and Practice of Infectious Diseases, 8th ed.; Douglas & Bennett's, Churchill, Livingston: New York, NY, USA, 1995; pp. 279-301. ISBN 978-1-4557-4801-3.
70. Montie, T.; Patamasucon, P. Aminoglycosides: The complex problem of antibiotic mechanisms and clinical applications. Eur. J. Clin. Microbiol. Infect. Dis. 1995, 14, 85-87.
71. Edson, R. S.; Terrell, C. L. The aminoglycosides. Mayo Clin. Proc. 1991, 66, 1158-1164.
72. Zhao, C.; Li, J.; Hou, J.; Guo, M.; Zhang, Y.; Chen, Y. A randomized controlled clinical trial, on etimicin, a new aminoglycoside antibiotic, versus netilmicin in the treatment of bacterial infections. Clin. Med. J. 2000, 113, 1026-1030.
73. Lortholary, O.; Tod, M.; Cohen, Y.; Petitjean, O. Aminoglycosides. Med. Clin. N. Am. 1995, 79, 761-787.
74. Kaelowsky, J. A.; Zelenitsky, S. A.; Zhanel, G. G. Aminoglycoside adaptive resistance. Pharmacotherapy 1997, 17, 549-555.
75. Neu, H. C. The crisis in antibiotic resistance. Science 1992, 257, 1064-1073.
76. Chang, C.-W. T.; Hui, Y.; Elchert, B.; Wang, J.; Li, J.; Rai, R. Pyranmycins, a novel class of aminoglycosides with improved acid stability: The SAR of D-pyranoses on ring III of pyranmycin. Org. Lett. 2002, 4, 4603-4606.
77. Rai, R.; Chang, H.; Chang, C.-W. T. Novel Method for the Synthesis of 3', 4'-Dideoxygenated Pyranmycin and Kanamycin Compounds, and Studies of Their Antibacterial Activity against Aminoglycoside Resistant Bacteria. J. Carbohydr. Chem. 2005, 24, 131-143.
78. Rai, R.; Chen, H.; Czyryca, P. G.; Li, J.; Chang, C.-W. T. Design and Synthesis of Pyrankacin: A Pyranmycin Class Broad Spectrum Aminoglycoside Antibiotic. Org. Lett. 2006, 8, 887-889.
79. Santana, A. G.; Zárate, S. G.; Asensio, J. L.; Revuelta, J.; Bastida, A. Selective modification of the 3"-amino group of kanamycin prevents significant loss of activity in resistant bacterial strains. Org. Biomol. Chem. 2016, 14, 516-525.
80. Galani, I.; Souli, M.; Daikos, G. L.; Chrysouli, Z.; Poulakou, G.; Psichogiou, M.; Panagea, T.; Argyropoulou, Stefanou, I.; Plakias, G.; Giamarellou, H.; et al. Activity of Plazomicin (ACHN-490) against MDR clinical isolates of Klebsiella pneumoniae, Escherichia coli, and Enterobacter spp. J. Chemother. 2012, 24, 191-194.
81. Mega, W. M.; Doyle-Eisele, M.; Cass, R. T.; Kostrub, C. F.; Sherwood, R. L.; Metz, M. A.; Cirz, R. T. Plazomicin is effective in a non-human primate pneumonic plague model. Bioorg. Med. Chem. 2016, 24, 6429-6439.
82. Livermore, D. M.; Mushtaq, S.; Warner, M.; Zhang, J. C.; Maharjan, S.; Doumith, M. Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates. J. Antimicrob. Chemother. 2011, 66, 48-53.
83. Francois, B.; Russell, R. J. M.; Murray, J. B.; Aboul-ela, F.; Masquida, B.; Vicens, Q.; Westhof, E. Crystal structures of complexes between aminoglycosides and decoding A site oligonucleotides: Role of the number of rings and positive charges in the specific binding leading to miscoding. Nucleic Acids Res. 2005, 33, 5677-5690.
84. Nuthanakanti, A.; Boerneke, M. A.; Hermann, T.; Srivatsan, S. G. Structure of the Ribosomal RNA Decoding Site Containing a Selenium-Modified Responsive Fluorescent Ribonucleoside Probe. Angew. Chem. Int. Ed. Engl. 2017, 56, 2640-2644.
85. Murray, J. B.; Meroueh, S. O.; Russell, R. J.; Lentzen, G.; Haddad, J.; Mobashery, S. Interactions of designer antibiotics and the bacterial ribosomal aminoacyl-tRNA site. Chem. Biol. 2006, 13, 129-138.
86. Revuelta, J.; Vacas, T.; Corzana, F.; González, C.; Bastida, A.; Asensio, J. L. Structure-Based Design of Highly Crowded Ribostamycin/Kanamycin Hybrids as a new Family of Antibiotics. Chem. A Eur. J. 2010, 16, 2986-2991.
87. Asensio, J. L.; Hidalgo, A.; Bastida, A.; Torrado, M.; Corzana, F.; García-Junceda, E.; Cañada, J.; Chiara, J. L.; Jimenez-Barbero, J. A simple structural-based approach to prevent aminoglycoside inactivation by bacterial defense proteins. Conformational restriction provides effective protection against neomycin-B nucleotidylation by ANT4". J. Am. Chem. Soc. 2005, 127, 8278-8279.
88. Blount, K. F.; Zhao, F.; Hermann, T.; Tor, Y. Conformational constraint as a means for understanding RNA-aminoglycoside specificity. J. Am. Chem. Soc. 2005, 127, 9818-9829.
89. Santana, A. G.; Bastida, A.; Martínez del Campo, T.; Asensio, J. L.; Revuelta, J. An efficient and general route to the synthesis of novel aminoglycosides for RNA binding. Synlett 2011, 219-222.
90. Sucheck, S. J.; Wong, A. L.; Koeller, K. M.; Boehr, D. D.; Draker, K.; Sears, P.; Wright, G. D. Design of bifunctional antibiotics that target bacterial rRNA and inhibit resistance-causing enzymes. J. Am. Chem. Soc. 2000, 122, 5230-5231.
91. Vacas, T.; Corzana, F.; Jiménez-Osés, G.; González, C.; Gómez, A. M.; Bastida, A.; Revuelta, J.; Asensio, J. L. Role of aromatic rings in the molecular recognition of aminoglycoside antibiotics: Implications for drug design. J. Am. Chem. Soc. 2010, 132, 12074-12090.
92. Mandhapati, A. R.; Yang, G.; Kato, T.; Shcherbakov, D.; Hobbie, S. N.; Vasella, A.; Boöttger, E. C.; Crich, D. Structure-Based Design and Synthesis of Apramycin-Paromomycin Analogues: Importance of the Configuration at the 6'-Position and Differences between the 6'-Amino and Hydroxy Series. J. Am. Chem. Soc. 2017, 139, 14611-14619.
93. Leban, N.; Kaplan, E.; Chaloin, L.; Godreuil, S.; Lionne, C. Kinetic characterization and molecular docking of novel allosteric inhibitors of aminoglycoside phosphotransferases. Biochim. Biophys. Acta 2017, 1861, 3464-3473.
94. Kotra, L. P.; Haddad, J.; Mobashery, S. Aminoglycosides: Perspectives on mechanisms of action and resistance and strategies to counter resistance. Antimicrob. Agents Chemother. 2000, 44, 3249-3256.
95. Boehr, D. D.; Draker, K. A.; Koteva, K.; Bains, M.; Hancock, R. E.; Wright, G. D. Broad-spectrum peptide inhibitors of aminoglycoside antibiotic resistance enzymes. Chem. Biol. 2003, 10, 189-196.
96. Gao, F.; Yan, X.; Baetting, O. M.; Berghuis, A. M.; Auclair, K. Regio- and chemoselective 6'-N-derivatization of aminoglycosides: Bisubstrate inhibitors as probes to study aminoglycoside 6'-N-acetyltransferases. Angew. Chem. Int. Ed. 2005, 44, 6859-6862.
97. Williams, J. W.; Northrop, D. B. Synthesis of a tight-binding, multisubstrate analog inhibitor of gentamicin acetyltransferase I. J. Antibiot. (Tokyo) 1979, 32, 1147-1154.
98. Liu, M.; Haddad, J.; Azucena, E.; Kotra, L. P.; Kirzhner, M.; Mobashery, S. Tethered bisubstrate derivatives as probes for mechanism and as inhibitors of aminoglycoside 3'-phosphotransferases. J. Org. Chem. 2000, 65, 7422-7431.
99. Roestamadji, J.; Grapsas, I.; Mobashery, S. Mechanism-based inactivation of bacterial aminoglycoside 3'-phosphotransferases. J. Am. Chem. Soc. 1995, 117, 80-84.
100. Allen, N. E.; Alborn, W. E., Jr.; Hobbs, J. N., Jr.; Kirst, H. A. 7'hydroxytropolone: An inhibitor of aminoglycoside-2"-O-adenyltrasfersae. Antimicrob. Agents Chemother. 1982, 22, 824-831.
101. Hirsch, D. R.; Cox, G.; D'Erasmo, M. P.; Shakya, T.; Meck, C.; Mohda, N.; Wright, G. D.; Murelli, R. P. Inhibition of the ANT (2")-Ia resistance enzyme and rescue of aminoglycoside antibiotic activity by synthetic α-hydroxytropolones. Bioorg. Med. Chem. Lett. 2014, 24, 4943-4947.
102. Garzan, A.; Willby, M. J.; Green, K. D.; Gajadeera, C. S.; Hou, C.; Tsodikov, O. V.; Posey, J. E.; Garneau-Tsodikova, S. Sulfonamide-Based Inhibitors of Aminoglycoside Acetyltransferase Eis Abolish Resistance to Kanamycin in Mycobacterium tuberculosis. J. Med. Chem. 2016, 59, 10619-10628.
103. Latorre, M.; Peñalver, P.; Revuelta, J.; Luis Asensio, J. L.; García-Junceda, E.; Bastida, A. Rescue of the streptomycin antibiotic activity by using streptidine as a "decoy acceptor" for the aminoglycosideinactivating enzyme adenyl transferase. Chem. Commun. 2007, 2829-2831.
104. Pokrovskaya, V.; Baasov, T. Dual-acting hybrid antibiotics: A promising strategy to combat bacterial resistance. Expert Opin. Drug Discov. 2010, 5, 883-902.
105. Berkov-Zrihen, Y.; Green, K. D.; Labby, K. J.; Feldman, M.; Garneau-Tsodikova, S.; Fridman, M. Synthesis and evaluation of hetero- and homodimers of ribosome-targeting antibiotics: Antimicrobial activity, in vitro inhibition of translation, and drug resistance. J. Med. Chem. 2013, 56, 5613-5625.
106. Xiao, Z. P.; Wang, X. D.; Wang, P. F. Design, synthesis, and evaluation of novel fluoroquinolone-flavonoid hybrids as potent antibiotics against drug-resistant microorganisms. Eur. J. Med. Chem. 2014, 80, 92-100.
107. Wong, W. T.; Chan, K. C.; So, P. K. Increased structural flexibility at the active site of a fluorophore-conjugated beta-lactamase distinctively impacts its binding toward diverse cephalosporin antibiotics. J. Biol. Chem. 2011, 286, 31771-31780.
108. Bremner, J. B.; Ambrus, J. I.; Samosorn, S. Dual action-based approaches to antibacterial agents. Curr. Med. Chem. 2007, 14, 1459-1477.
109. Hainrichson, M.; Pokrovskaya, V.; Shallom-Shezifi, D. Branched aminoglycosides: Biochemical studies and antibacterial activity of neomycin B derivatives. Bioorg. Med. Chem. 2005, 13, 5797-5807.
110. Shavit, M.; Pokrovskaya, V.; Belakhov, V.; Baasov, T. Covalently linked kanamycin-Ciprofloxacin hybrid antibiotics as a toolto fight bacterial resistance. Bioorg. Med. Chem. 2017, 25, 2917-2925.
111. Pokrovskaya, V.; Nudelman, I.; Kandasamy, J.; Baasov, T. Aminoglycosides: Redesign Strategies for Improved Antibiotics and Compounds for Treatment of Human Genetic Diseases. In Methods in Enzymology, 1st ed.; Fukuda, M., Ed.; Elsevier Inc.: Amsterdam, The Netherlands, 2010; Charper 21 Glycomics; Volume 478, pp. 437-462. ISSN 0076-6879.
112. Serpersu, E. H.; Norris, A. L. Effect of protein dynamics and solvent in ligand recognition by promiscuous aminoglycoside-modifying enzymes. In Advances in Carbohydrate Chemistry and Biochemistry; Elsevier Inc.: Amsterdam, The Netherlands, 2012; Volume 67, pp. 222-243. ISBN 978-0-12-396527-1.
113. Herzog, I. M.; Zada, S. L.; Fridman, M. Effects of 5-O-Ribosylation of Aminoglycosides on Antimicrobial Activity and Selective Perturbation of Bacterial Translation. J. Med. Chem. 2016, 59, 8008-8018.